The evolving therapeutic landscape of advanced #HCC has led to an increasing number of patients receiving second-line and subsequent therapies.
But what are the best treatment options in these later lines?
👉️ buff.ly/HfRsAXL
#OncSky #GISky
The evolving therapeutic landscape of advanced hepatocellular carcinoma has led to an increasing number of patients receiving second-line and subsequent therapies. But what are the best treatment…